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Background. Norepinephrine (NE) is the major endogenous
neurotransmitter of the renal sympathetic nerves interacting with
both the a- and b-adrenoceptors in the renal proximal tubules.
We have previously reported that isoproterenol and iodoclonidine
stimulate the expression of the angiotensinogen (ANG) gene in
opossum kidney (OK) proximal tubular cells via the b1-adreno-
ceptor and a2-adrenoceptor, respectively. We hypothesized that
NE may interact with the b- and/or a2-adrenoceptors to stimulate
the expression of the ANG gene in OK cells.
Methods. The fusion genes containing the various lengths of the
59-flanking regulatory sequence of the rat ANG gene fused with a
human growth hormone (hGH) gene as a reporter were stably
transfected into the OK cells. The stimulatory effect of NE on the
expression of the fusion genes was evaluated by the amount of
immunoreactive hGH (IR-hGH) secreted into the culture me-
dium.
Results. The addition of NE stimulated the expression of the
fusion gene, pOGH (ANG N-1498/118) in a dose-dependent
manner. The stimulatory effect of NE was inhibited in the
presence of propranolol, atenolol, Rp-cAMP, yohimbine, stauro-
sporine, H-7 and U73122 but not in the presence of ICI 118,551
and prazosin. The addition of a combination of isoproterenol and
iodoclonidine synergistically stimulated the expression of pOGH
(ANG N-1498/118) as compared to the addition of isoproterenol
and iodoclonidine alone. Furthermore, the addition of NE, fors-
kolin, 8-Br-cAMP or phorbol 12-myristate (PMA) stimulated the
expression of pOGH (ANG N-806/-779/-53/118), a fusion gene
containing the putative cAMP responsive element (CRE, ANG
N-806/-779) upstream of the ANG promoter (ANG N-53/118) in
OK 95 cells, but had no effect on the expression of fusion genes
containing the mutant of the CRE.
Conclusion. These studies demonstrate that the stimulatory
effect of NE on the expression of the ANG gene in OK cells may
be mediated via both the b1- and a2-adrenoceptors and via the
CRE (ANG N-806/-779) in the 59flanking region of rat ANG
gene.
The existence of an intrarenal renin-angiotensin system
(RAS) has now been generally accepted [1, 2]. Angio-
tensinogen (ANG) mRNA has been localized in rat prox-
imal tubules by the techniques of in situ hybridization [3]
and polymerase chain reaction (PCR) [4]. Recent studies
have also shown that the mRNA components of RAS,
including ANG, renin, angiotensin-converting enzyme and
angiotensin II receptor (AT1-receptor) are expressed in
murine (mouse and rat) immortalized proximal tubular cell
lines [5, 6]. We [7] as well as Ingelfinger et al [8] have also
demonstrated that the ANG mRNA is expressed in opos-
sum kidney (OK) proximal tubular cells. Thus, these stud-
ies demonstrate that the intrarenal angiotensin II (Ang II)
is probably derived from the ANG that is synthesized by the
renal proximal tubular cells.
We have previously reported that isoproterenol and
iodoclonidine stimulate the expression of the ANG gene in
OK cells [9, 10]. The effect of isoproterenol is mediated via
the b1-adrenoceptor and cAMP-dependent protein kinase
A (PKA) pathway [9], whereas the effect of iodoclonidine
is mediated via the a2-adrenoceptor and protein kinase C
(PKC) pathway [10]. Our studies confirm the reports of
Nakamura and Johns [11] that low levels of renal nerve
stimulation increase the ANG mRNA levels in the rat
kidney in vivo. Furthermore, our studies [9, 10] and those of
Nakamura and Johns [11] together indicate the presence of
a functional relationship between the renal sympathetic
nervous system and the activation of local intrarenal RAS.
Thus, the local formation of renal Ang II may play an
important role in the physiology of the renal proximal
tubular cells (that is, sodium and fluid reabsorption) [12–
15].
Norepinephrine (NE) is the major endogenous neuro-
transmitter of the renal sympathetic nerves [16, 17] and it
interacts with both the a- and b-adrenoceptors in the renal
proximal tubules [18–21]. Thus, the objective of the present
studies was to investigate whether NE modulates the
expression of the ANG gene in OK cells. Our studies
showed that addition of NE stimulates the expression of the
ANG gene via both b1-and a2-adrenoceptors and their
respective PKA and PKC pathways. Moreover, we demon-
strated that the effect of NE on the expression of the ANG
Key words: catecholamines, renin-angiotensin system, kidney.
Received for publication November 20, 1997
and in revised form April 15, 1998
Accepted for publication April 16, 1998
© 1998 by the International Society of Nephrology
Kidney International, Vol. 54 (1998), pp. 785–795
785
gene is mediated via the putative cAMP-responsive ele-
ment (CRE) in the 59-flanking region of the ANG gene.
METHODS
Materials
The plasmid, pRSV-Neo, containing the coding se-
quence for Neomycin (Neo) with the Rous Sarcoma Virus
(RSV) enhancer/promoter sequence fused in the 59-end of
the Neomycin gene was a gift from Dr. Teresa Wang (Dept.
of Pathology, Stanford University, Stanford, CA, USA).
The plasmid, pTKGH, containing the thymidine kinase
(TK) enhancer/promoter sequence fused to the 59-end of
the hGH gene was purchased from the Nichols Institute of
Diagnostics (La Jolla, CA, USA).
The radioimmunoassay kit for hGH (RIA-hGH) was a
gift from NIADDK (NIH, Bethesda, MD, USA). The RIA
procedure has been described previously [22]. NIAMDD-
hGH-I-1 (AFP-4793 B) was used for both iodination and as
a hormone standard. The limit of sensitivity of the assay
was 0.1 ng/ml. The inter- and intra-assay coefficients of
variation were 10% (N 5 10) and 12% (N 5 10), respec-
tively.
Yohimbine hydrochloride (a2-adrenoceptor antagonist),
P-iodoclonidine hydrochloride (a2-adrenoceptor agonist),
prazosin hydrochloride (a1-adrenoceptor antagonist),
R(2)-isoproterenol (1)-bitartrate salt (b-adrenoceptor ag-
onist), atenolol (b1-adrenoceptor antagonist), ICI 118,551
(b2-adrenoceptor antagonist), phorbol 12-myristate 13-ac-
etate (PMA, a stimulator of protein kinase C), staurospor-
ine (an inhibitor of protein kinase C), H-7 (an inhibitor of
protein kinase C), U73122 (an inhibitor of phospholipase C
and A2), S(2)-propranolol hydrochloride (an inhibitor of
b1- and b2-adrenoceptors), 8-bromo-cAMP, forskolin, Rp-
cAMP (an inhibitor of the cAMP-dependent protein kinase
A I and II) were all purchased from Research Biochemicals
Inc (RBI, Natick, MA, USA). (2)Arterenol bitartrate
(norepinephrine) was purchased from Sigma Chemicals
(St. Louis, MO, USA).
Oligonucleotides for the putative CRE of the rat ANG
gene (ANG-CRE), N-806 to N-779 (59 AAG AGA TTA
CTT GAC GTA CTG GAT GCA A 39) [22], mutant 1
(M1) (59 AAG AGA TTA CTT GAC TTA CTG GAT
GCA A 39), mutant 2 (M2) (59 AAG AGA TTA CTT GAA
TTA CTG GAT GCA A 39) and mutant 3 (M3) (59 AAG
AGA TTA CTT ATA TTA CTG GAT GCA A 39) were
synthesized by Biosynthesis, Inc. (Lewisville, TX, USA).
Na125I was purchased from Dupont, New England Nu-
clear (NEN, Boston, MA, USA). Calcium chloride was
purchased from Mallinckrodt, Inc. (Montreal, Quebec,
Canada); Geneticin (G 418) was purchased from Bethesda
Research Laboratories (Gibco-BRL, Burlington, Ontario,
Canada). Other molecular biology grade reagents were
obtained either from Sigma Chemicals, Gibco-BRL, Boeh-
ringer-Mannheim (Dorval, Quebec, Canada), Pharmacia
Inc. (Baie d’Urfe, Quebec, Canada) or Promega-Fisher,
Inc. (Montreal, Quebec, Canada).
Construction of fusion genes
The method of construction of the ANG-GH fusion
genes, pOGH (ANG N-1498/118), pOGH (ANG N-960/
118), pOGH (ANG N-688/118), pOGH (ANG N-280/
118) and pOGH (ANG N-53/118) has been described
previously [22]. To construct the fusion genes, pOGH
(ANG N-806/-779/-53/118), and its mutants (that is, M1,
M2, and M3), the double-strand DNA fragment (ANG
N-806/-779) with the HindIII enzyme restriction site on
both the 59 and 39-ends was inserted upstream of the
minimal promoter of rat ANG gene (ANG N-53/118) in
the pOGH (ANG N-53/118) [22] that had been previously
digested with the restriction enzyme HindIII and alkaline
phophatase.
The sequence and orientation for the fusion genes were
confirmed by dideoxy sequencing with SP6 primer (Pro-
mega-Fisher, Inc.) and restriction enzyme digestion map-
ping.
Cell culture
The opossum kidney (OK) proximal tubular cell line was
obtained from the American Tissue Culture Collection
(ATCC; Rockville, MD, USA). This cell line is derived
from the kidney of a female American opossum and retains
several properties of proximal tubular epithelial cells in
culture [23, 24] and expresses a low level of ANG mRNA
[7, 8]. The culture conditions of the OK cells have been
described previously [9, 10, 25].
OK cell stable transformants
OK 27, OK 960, OK 688, OK 280, OK 53 and OK 13 cells
are stable transformants with pOGH (ANG N-1498/118),
pOGH (ANG N-960/118), pOGH (ANG N-688/118),
pOGH (ANG N-280/118), pOGH (ANG N-53/118) and
pTKGH integrated into OK cellular genomes, respectively.
The method of obtaining these transformants had been
previously reported [9, 10]. Briefly, the ANG-GH fusion
gene and the plasmid pRSV-Neo were co-transfected (20
mg) each into OK cells utilizing calcium phosphate-medi-
ated endocytosis. The stable transformants were selected by
growing the cells in the presence of G418 (Geneticin;
Gibco, Inc.). OK 95, OK 95/M1, OK 95/M2, OK 95/M3
cells are stable transformants with pOGH (ANG N-806/-
779/N-53/118) or its mutants and pRSV-Neo fusion genes
co-integrated into OK cellular genomes. The method for
the selection of OK cell stable transformants with the high
expression of the fusion gene was identical to the method
described previously for OK 27 cells [9, 10].
Effect of norepinephrine on the expression of the ANG-
GH fusion gene in OK cell stable transformants
OK cell stable transformants were plated at a density of
1 to 2 3 105 cells/well in six-well plates and incubated
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overnight in DMEM containing 10% FBS. Then, cell
growth was arrested by incubation in serum-free medium
for 24 hours. Subsequently, various concentrations of NE
(10213 to 1025 M) were added to the culture medium
containing 1% resin and charcoal-treated FBS and incu-
bated for 24 hours. At the end of the incubation period,
media were collected and kept at 220°C until assayed for
IR-hGH.
To compare the inhibitory effect of propranolol, ateno-
lol, ICI 118,551, yohimbine, prazosin, Rp-cAMP, stauro-
sporine, H-7 and U73122 on the expression of ANG-GH
fusion gene in OK cell transformants, various concentra-
tions (10213 to 1027 M) of the antagonists or inhibitors were
added in the presence of NE (1029 M) for 24 hours. At the
end of the incubation period, media were collected and
kept at 220°C until assay for IR-hGH.
To compare the effect of NE on the expression of various
fusion genes in OK 960, OK 688, OK 280, OK 53 and OK
13 cells, NE (1029 M) was added to the culture medium
containing 1% resin and charcoal-treated FBS and incu-
bated for 24 hours. At the end of the incubation period,
media were collected and kept at 220°C until assayed for
IR-hGH.
The resin and charcoal-treated FBS was prepared by
incubation with 1% activated charcoal and 1% AG 1 3 8
ion-exchange resin (Bio-Rad Laboratories, Richmond, CA,
USA) for 16 hours or more at room temperature as
described by Samuels, Stanley and Shapiro [26]. This
procedure removed endogenous steroid and thyroid hor-
mones from the FBS as demonstrated by Samuels et al [26].
Statistical analysis
The experiments were performed at least three to four
times in triplicate. The data were analyzed with Student’s
t-test or analysis of variance (ANOVA). A probability level
of P # 0.05 was regarded as significant.
RESULTS
Effect of norepinephrine on the expression of ANG-GH
fusion genes in OK cell stable transformants
Figure 1 shows the expression of the pOGH (ANG
N-1498/118) in OK 27 cells in the presence of various
concentrations (10213 to 1025 M) of NE. A dose-dependent
relationship between NE concentrations and the stimula-
tion of expression of pOGH (ANG N-1498/118) was
observed for NE at 10213 M to 1027 M. The maximal
stimulation of expression of the pOGH (ANG N-1498/
118) was found with 1029 M to 1027 M for NE, whereas the
addition of concentrations greater than 1027 M (that is,
1025 M) of norepinephrine had no effect.
Figure 2 shows the effect of NE (1029 M) or isoprotere-
nol (1029 M) or iodoclonidine (1029 M) on the expression of
the pOGH (ANG N-1498/118) in OK 27 cells without (Fig.
2A) or with (Fig. 2B) the pre-incubation with a high
concentration of NE (1025 M) for 24 hours. It is apparent
that the pre-incubation of OK 27 cells with NE (1025 M)
abolished the stimulatory effect of NE, isoproterenol or
iodoclonidine on the expression of the pOGH (ANG
N-1498/118; Fig. 2B). These studies suggest that the
pre-incubation with high concentrations of NE (1025 M)
will desensitize or down-regulate the b- and a2-adrenocep-
tors in OK 27 cells.
Figure 3 shows that addition of either propranolol or
yohimbine inhibits the stimulatory effect of NE on the
expression of the pOGH (ANG N-1498/118) in OK 27
cells in a dose-dependent manner. The effective dose for
the inhibition of the stimulated expression (by norepineph-
rine) of the pOGH (ANG N-1498/118) was found with
10211 M of propranolol (P # 0.05) and 1029 M yohimbine
(P # 0.05). Yohimbine or propranolol at 1027 M completely
inhibited the stimulatory effect of NE (P # 0.01). These
studies suggest that the stimulatory effect of NE is medi-
ated via both b1-adrenoceptor and a2-adrenoceptor.
The inhibitory effect of various adrenoceptor antagonists
on the expression of the pOGH (ANG N-1498/118) in OK
27 cells stimulated by NE (1029 M) is shown in Figure 4.
Propranolol, atenolol and yohimbine at 1027 M completely
inhibited the stimulatory effect of NE (P # 0.01), whereas
ICI 118,551 and prazosin had no effect. The studies further
confirm that the effect of NE is mediated via both b1-
adrenoceptor and a2-adrenoceptor.
Figure 5 shows that addition of Rp-cAMP, staurosporine
or U73122 inhibits the stimulatory effect of NE on the
expression of pOGH (ANG N-1498/118) in OK 27 cells in
a dose-dependent manner. The maximal and half-maximal
inhibition of the stimulated expression of the pOGH (ANG
Fig. 1. Effect of norepinephrine on the expression of pOGH (ANG
N-1498/118) in OK 27 cells. Cells were incubated for up to 24 hours in the
presence of various concentrations of norepinephrine (10213 to 1025 M).
Media were harvested after 24 hours of incubation and assayed for
immunoreactive human growth hormone (IR-hGH). The concentrations
of IR-hGH in the absence of norepinephrine represents the control level
(that is, 1.65 6 0.03 ng/ml of IR-hGH). Each point represents the mean 6
SD of three determinations (*P # 0.05, **P # 0.01 and ***P # 0.005).
Similar results were obtained from three other experiements.
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N-1498/118) was found with 1027 M (P # 0.01) and 10211
M (P # 0.05) Rp-cAMP. These studies indicate that the
cAMP-dependent protein kinase AI and II is involved in
the expression of the fusion gene stimulated by NE. Simi-
larly, the maximal and half-maximal inhibition of the
stimulated expression of the pOGH (ANG N-1498/118)
was found with 1027 M (P # 0.05) and 10211 M (P # 0.01)
staurosporine or U73122, respectively. The addition of H-7
(an inhibitor of PKC) also inhibited the stimulatory effect
of NE on the expression of pOGH (ANG N-1498/118) in
OK 27 cells in a dose-dependent manner (Fig. 6). The
maximal and half-maximal inhibition of the stimulated
expression of the pOGH (ANG N-1498/118) was found
with 1027 M (P # 0.01) and 1029 M (P # 0.05), respectively.
These studies indicate that protein kinase C may also
mediate the effect of NE on the expression of the ANG
gene in OK cells.
Effect of a combination of both iodoclonidine and
isoproterenol on the expression of pOGH (ANG N-1498/
118) in OK 27 cells
Figure 7 shows that the stimulatory effect of NE on the
expression of pOGH (ANG N-1498/118) was similar to the
addition of isoproterenol or iodoclonidine alone. The ad-
dition of a combination of both isoproterenol and iodo-
clonidine, however, significantly enhanced the expression
of the pOGH (ANG N-1498/118; that is, 230%) compared
to the addition of isoproterenol (145%) or iodoclonidine
(146%) alone (P # 0.05). These studies indicate that there
is probably a synergistic effect of both b1- and a2-adreno-
ceptors on the expression of pOGH (ANG N-1498/118) in
OK 27 cells.
Effect of NE on the expression of ANG-GH fusion genes
and pTKGH in OK cells
Figure 8 shows that the addition of NE (1029 M) stimu-
lated the expression of pOGH (ANG N-1498/118), pOGH
(ANG N-960/118), pOGH (ANG N-688/118) in OK 27,
OK 960 and OK 688 cells compared to the controls (that is,
without the addition of NE), respectively. The addition of
NE had no stimulatory effect on the expression of pOGH
(ANG N-280/118), pOGH (ANG N-53/118) and pTKGH
in OK 280, OK 53 and OK 13 cells compared to the
controls, respectively.
Effect of NE on the expression of pOGH (ANG N-806/-
779/-53/118) in OK 95 cells
Figure 9 shows that the presence of propranolol or
yohimbine inhibited the stimulatory effect of NE on the
expression of pOGH (ANG N-806/-779/-53/118) in OK 95
cells in a dose-dependent manner. The maximal and half-
maximal inhibition of the stimulated expression of the
Fig. 2. Effect of norepinephrine, isoproterenol and iodoclonidine on the
expression of the pOGH (ANG N-1498/118) in OK 27 cells when the cells
were pre-incubated with a high level of norepinephrine. Cells were
pre-incubated for 24 hours without (A) or with (B) 1025 M norepinephrine.
Then the media were replaced with the fresh media containing 1029 M
norephinephrine or 1029 M isoproterenol or 1029 M iodoclonidine and
incubated further for 24 hours. Subsequently, the media were harvested
and assayed for IR-hGH. The concentration of IR-hGH in the medium
without the addition of drugs in A or B (that is, 2.5 6 0.1 ng/ml or 4.0 6
0.4 ng/ml) is expressed as 100% (control). Each point represents the
mean 6 SD of three dishes (*P # 0.05, **P # 0.01 and ***P # 0.005).
Symbols are: (M) control medium without the addition of drugs; (f)
medium in the presence of 1029 M norepinephrine; (;) medium in the
presence of 1029 M isoproterenol; (o) medium in the presence of 1029 M
iodoclonidine. Similar results were obtained from two other experiments.
Fig. 3. Inhibitory effect of propranolol (b-adrenoceptor antagonist) or
yohimbine (a2-adrenoceptor antagonist) on the expression of pOGH
(ANG N-1498/118) in OK 27 cells stimulated by norepinephrine. The
cells were incubated for up to 24 hours in the presence of norepinephrine
(1029 M) and various concentrations of propranolol (10213 to 1027 M) or
yohimbine (10213 to 1027 M). Media were harvested and assayed for the
level of IR-hGH. The concentration of IR-hGH in the absence of NE or
propranolol or yohimbine represents the control level (1.53 6 0.06 ng/ml
of IR-hGH). The inhibitory effect of propranolol or yohimbine was
compared to cells that were incubated with 1029 M norepinephrine.
Results are expressed as the mean 6 SD of three determinations (*P #
0.05, **P # 0.01 and ***P # 0.005). Symbols are: (E) propranolol; (F)
yohimbine. Experiments were repeated three times.
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pOGH (ANG N-806/-779/-53/118) was found with 1027 M
and 10211 M propranolol or yohimbine, respectively. These
studies indicate that the effect of NE on the expression of
pOGH (ANG N-806/-779/-53/118) is mediated via both b1-
and a2-adrenoceptors, respectively.
Figure 10 shows the result of the addition of 8-bromo-
cAMP, forskolin and PMA on the expression of the pOGH
(ANG N-806/-779/-53/118) in OK 95 cells. The addition of
8-bromo-cAMP (1023 M), forskolin (1029 M) or PMA (1029
M) significantly stimulated the expression of pOGH (ANG
N-806/-779/-53/118) in OK 95 cells compared to the con-
trols (that is, absence of 8-bromo-cAMP, forskolin or
PMA). Since the DNA fragment, ANG N-806/-779 con-
tains the DNA sequence, TGACGTAC (N-795 to N-788)
which is very similar to the consensus CRE (that is,
TGACGTCA), these studies indicate that the DNA frag-
ment, ANG N-806/-779, is probably the functional CRE of
the rat ANG gene.
Figure 11 shows that the addition of Rp-cAMP (1027 M),
U73122 (1027 M) or staurosporine (1027 M) also inhibited
the stimulatory effect of NE on the expression of pOGH
(ANG N-806/-779/-53/118) in OK 95 cells. These studies
demonstrate that the stimulatory effect of NE on the
expression of pOGH (ANG N-806/-779/-53/118) in OK 95
cells is mediated via both PKA and PKC signal transduc-
tion pathway.
Figure 12 shows that the addition of NE (1029 M),
8-Br-cAMP (1023 M) or PMA (1027 M) had no stimulatory
effect on the expression of the mutants (that is, M1, M2 and
M3) of pOGH (ANG N-806/-779/-53/118) in OK 95/M1,
OK 95/M2 and OK 95/M3 cells compared to the control
(without the addition of NE, forskolin or PMA). These
studies demonstrate that the DNA sequence, TGACGTAC
(N-795/-788) is the motif of the cAMP-responsive element
(CRE; that is, ANG N-806/-779) of the rat ANG gene.
Effect of NE or forskolin or 8-Br-cAMP or PMA on the
expression of pOGH (ANG N-53/118) in OK 53 cells
Figure 13 shows that addition of NE (1029 M) or
forskolin (1027 M) or 8-Br-cAMP (1023 M) or PMA (1029
M) had no stimulatory effect on the expression of pOGH
(ANG N-53/118) in OK 53 cells. These studies indicate
that the minimal promoter (ANG N-53 to N118) of the rat
ANG gene is not sufficient to respond to the addition of
NE or PKA or PKC signal transduction pathways.
DISCUSSION
Our present studies showed that addition of NE alone
directly stimulated the expression of pOGH (ANG N-1498/
Fig. 4. Inhibitory effect of adrenoceptor antagonists on the expression of pOGH (ANG N-1498/118) in OK 27 cells stimulated by norepinephrine
(1029 M). OK 27 cells were incubated for up to 24 hours in the presence of norepinephrine (1029 M) and 1027 M of various adrenoceptor antagonists.
Media were harvested and assayed for the level of IR-hGH. The concentration of IR-hGH in the absence of norepinephrine or adrenoceptor antagonists
is the control level (that is, 1.45 6 0.06 ng/ml of IR-hGH). The inhibitory effect of adrenoceptor antagonists was compared to cells that were incubated
with 1029 M norepinephrine. Results were expressed as the mean 6 SD of three determinations (*P # 0.05, **P # 0.01 and ***P # 0.005). Similar results
were obtained from two other experiments.
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118) in OK 27 cells in a dose-dependent manner (that is,
10213 to 1027 M; Fig. 1). At present, we do not understand
why higher concentrations of NE (that is, 1025 M) had no
stimulatory effects on the expression of the pOGH (Ang
N-1498/118) in OK 27 cells. One possible explanation may
be that the exposure of OK cells to high levels of NE may
desensitize or downregulate its own adrenoceptors. Indeed,
our studies (Fig. 2B) showed that the pre-incubation of OK
27 cells with 1025 M NE abolished the stimulatory effect of
NE, isoproterenol and iodoclonidine, supporting the notion
that the b- and a-adrenoceptors are subject to desensitiza-
tion by high levels of NE. Furthermore, these results are
supported by the observations of Suzuki et al [27] and
Kurose and Lefkowitz [28] that b- and a-adrenoceptors are
subject to desensitization by their own agonists. Obviously,
more experiments along these lines are warranted.
The stimulatory effect of NE was inhibited by the
presence of propranolol or yohimbine (Fig. 3) as well as by
the presence of atenolol, but not ICI 118,511 and prazosin
(Fig. 4). These studies demonstrate that the effect of NE
may be mediated via both b1-adrenoceptor and a2-adreno-
ceptor. These studies confirm our previous studies that the
activation of the b-adrenoceptor or a2-adrenoceptor alone
stimulated the expression of pOGH (ANG N-1498/118) in
OK 27 cells [9, 10].
The addition of Rp-cAMP, staurosporine or H-7 inhib-
ited the stimulatory effect of NE (1029 M) in a dose-
dependent manner (Figs. 5 and 6). These studies indicate
that the stimulatory effect of NE may be mediated via
either the cAMP-dependent protein kinase A I and II or
Fig. 5. Inhibitory effect of Rp-cAMP or staurosporine or U73122 on the
expression of pOGH (ANG N-1498/118) in OK 27 cells stimulated by
norepinephrine. Cells were incubated for up to 24 hours in the presence
of norepinephrine (1029 M) and various concentrations of Rp-cAMP
(10213 to 1027 M) or staurosporine (10213 to 1027 M) or U73122 (10213 to
1027 M). Media were harvested and assayed for the level of IR-hGH. The
concentration of IR-hGH in the absence of NE or Rp-cAMP or stauro-
sporine or U73122 is the control level (that is, 2.25 6 0.06 ng/ml of
IR-hGH). The inhibitory effect of Rp-cAMP or staurosporine or U73122
was compared to cells that were incubated with 1029 M norepinephrine.
Each point represents the mean 6 SD of three determinations (*P # 0.05,
**P # 0.01 and ***P # 0.005). Symbols are: (F) Rp-cAMP; (E)
staurosporine; (M) U73122. Similar results were obtained from two other
experiments.
Fig. 6. Inhibitory effect of H-7 on the expression of pOGH (ANG
N-1498/118) in OK 27 cells stimulated by norepinephrine. The cells were
incubated for 24 hours in the presence of norepinephrine (1029 M) and
various concentrations of H-7 (10213 to 1027 M). Media were harvested
and assayed for the level of IR-hGH. The concentration of IR-hGH in the
absence of NE represents the control level (that is, 3.14 6 0.2 ng/ml of
IR-hGH). The inhibitory effect of H-7 was compared to cells which were
incubated with 1029 M norepinephrine. Results are expressed as the
mean 6 SD of three determinations (*P # 0.05, **P # 0.01 and ***P #
0.005). Similar results were obtained from another experiment.
Fig. 7. Effect of a combination of both isoproterenol and iodoclonidine
on the expression of pOGH (ANG N-1498/118) in OK 27 cells. Cells were
incubated for up to 24 hours in the presence of NE (1029 M) or
isoproterenol (1029) or iodoclonidine (1029 M) or a combination of both
isoproterenol (1029 M) and iodoclonidine (1029 M). Media were harvested
after 24 hours of incubation and assayed for IR-hGH. The concentration
of IR-hGH in the absence of NE or adrenoceptor agonists represents the
control level (that is, 3.79 6 0.05 ng/ml of IR-hGH). Each point represents
the mean 6 SD of three determinations (*P # 0.05, **P # 0.01 and ***P #
0.005). Similar results were obtained from two other experiments.
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PKC signal transduction pathways or via the interaction of
both pathways in OK 27 cells. The involvement of the PKC
pathway is further supported by the observation that
U73122 inhibited the stimulatory effect of NE (Fig. 5).
Since U73122 is an inhibitor of phospholipase C and
phospholipase A2, it is conceivable that the addition of
U73122 might prevent the hydrolysis of phosphatidyl-
inositol 4,5 biphosphate and would subsequently inhibit the
activation of protein kinase C in OK 27 cells. Indeed, this
possibility is supported by the studies of Martin et al, who
showed that the addition of U73122 abolishes the increase
Fig. 8. Effect of norepinephrine on the
expression of various ANG-GH fusion genes in
OK cells. Cells were incubated for up to 24
hours in the presence of norepinephrine (1029
M). Media were harvested after 24 hours of
incubation and assayed for IR-hGH. The
concentration of IR-hGH in the medium
without norepinephrine (that is, OK 27 cells,
1.45 6 0.03 ng/ml; OK 960, 1.29 6 0.04 ng/ml;
OK 688, 3.24 6 0.2 ng/ml; OK 280, 0.37 6 0.02
ng/ml; OK 53, 0.44 6 0.02 ng/ml; OK 13,
5.56 6 0.3 ng/ml) is considered as the control
level. Each point represents the mean 6 SD of
three dishes (*P # 0.05, **P # 0.01 and
***P # 0.005). Similar results were obtained
from two other experiments.
Fig. 9. Inhibitory effect of propranolol or yohimbine on the expression of
pOGH (ANG N-806/-779/-53/118) in OK 95 cells stimulated by norepi-
nephrine (1029 M). OK 95 cells were incubated for up to 24 hours in the
presence of norepinephrine (1029 M) and various concentrations (10213 to
1027 M) of propranolol or yohimbine. Media were harvested and assayed
for the level of IR-hGH. The concentration of IR-hGH in the absence of
norepinephrine or propranolol or yohimbine is the control level (that is,
3.25 6 0.06 ng/ml). The inhibitory effect of propranolol or yohimbine was
compared to cells which were incubated with 1029 M norepinephrine.
Results are expressed as the mean 6 SD of three determinations (*P #
0.05, **P # 0.01 and ***P # 0.005). Symbols are: (E) propranolol; (F)
yohimbine. Similar results were obtained from two other experiments.
Fig. 10. Effect of 8-bromo-cAMP, forskolin and PMA on the expression
of pOGH (ANG N-809/-779/-53/118) in OK 95 cells. Cells were incubated
for 24 hours in the presence of 1023 M 8-Br-cAMP or 1029 M forskolin or
1029 M PMA. The levels of IR-hGH in the media were assayed by
RIA-hGH. The concentration of IR-hGH in the absence of 8-bromo-
cAMP, forskolin or PMA is the control (that is, 2.82 6 0.12 ng/ml of
IR-hGH). Each point represents the mean 6 SD of three determinations
(*P # 0.05, **P # 0.01 and ***P # 0.005). Similar results were obtained
from two other experiments.
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in particulate PKC activity stimulated by PTH in OK cells
[29]. Our preliminary results also showed that the stimula-
tory effect of NE (1029 M) and iodoclonidine (1029 M) was
abolished after a 24 hours pre-incubation of OK 27 cells
with 1025 M PMA compared to the control cells without the
pre-incubation with PMA (unpublished results). These
results are in agreement that the exposure to PMA will
downregulate the PKC activity [30]. Moreover, our prelim-
inary studies showed that NE at 1029 M increased the
cellular level of DAG and PKC activity in OK cells but not
NE at 1025 M (unpublished results). All these studies
support the notion that the stimulatory effect of NE is
mediated, at least in part, via the PKC signal transduction
pathway.
At present, we do not have a good explanation for the
results that the addition of 1027 M atenolol, yohimbine,
staurosporine, U73122 or H-7 alone completely inhibited
the NE (1029 M) stimulation of ANG gene expression (Figs.
3 to 6). One possible explanation may be that the dose 1027
M was too high (100-fold excess), since equal molar con-
centration (1029 M) of atenolol, yohimbine, staurosporine,
U73122 or H-7 could only partially block the stimulatory
effect of NE. The second possible explanation may be that
there are multiple isoform(s) of PKC and adenylyl cyclase
(AC) in OK cells. The effect of NE may be mediated via the
interaction or “cross-talk” of these isoforms of PKC and
AC. Indeed, studies have shown that PKC may interact
with specific subtypes of AC but not others in a cell-specific
manner [31]. Thus, it is possible that the addition of high
levels (1027 M) of atenolol, yohimbine, staurosporine,
U73122 or H-7 might block the “cross-talk” between the
PKC and PKA signal transduction pathway. Studies are
underway in our laboratory to identify the isoform(s) of
PKC and AC in OK cells.
Most interestingly, the stimulatory effect of the addition
of a combination of both isoproterenol and iodoclonidine
on the expression of the pOGH (ANG N-1498/118) was
significantly higher than the addition of isoproterenol and
iodoclonidine alone (P # 0.05; Fig. 7), suggesting a syner-
gistic effect of b- and a2-adrenoceptors. Since the effect of
b- and a2-adrenoceptors are mediated via protein kinase A
(PKA) and protein kinase C (PKC) in OK 27 cells,
respectively [9, 10], these studies support the notion that
there might be a “cross-talk” between the b- and a2-
adrenoceptors or between the activation of PKA and PKC
on the expression of pOGH (ANG N-1498/118) in OK 27
cells. These results are similar to our recent report [32] that
the addition of a combination of SKF-82958 (a D1-dopa-
minergic receptor agonist) and PPHT (a D2-dopaminergic
receptor agonist) significantly enhanced the expression of
pOGH (Ang N-1498/118) in OK 27 cells compared to the
addition of SKF-82958 or PPHT alone. The effect of
SKF-82958 and PPHT are mediated via the PKA and PKC
signal transduction pathway, respectively [32]. At present,
we do not understand the molecular mechanism(s) for the
synergistic effect of b- and a2-adrenoceptors in OK cells.
Experiments are underway in our laboratory to explore the
molecular mechanism(s) of the synergistic effect of b- and
a2-adrenoceptors on the expression of the ANG gene in
OK cells.
Our present results showed that the addition of NE
(1029 M) stimulates the expression of pOGH (ANG
N-1498/118), pOGH (ANG N-960/118) and pOGH
(ANG N-688/118) in OK 27, OK 960 and OK 688 cells,
respectively. The addition of NE (1029 M), however, had no
effect on the expression of pOGH (ANG N-280/118),
pOGH (ANG N-53/118) and pTKGH in OK 280, OK 53
and OK 13 cells, respectively (Fig. 8). These studies indi-
cate that the NE-responsive element is probably localized
within nucleotides N-1498 to N-280 in the 59-flanking
region of the rat ANG gene. Indeed, this possibility is
supported by those studies (Fig. 9) that the addition of NE
(1029 M) stimulated the expression of the pOGH (ANG
N-806/-779/-53/118) in OK 95 cells. The DNA fragment,
ANG N-806/-779 contains a CRE-motif (that is, N-795 to
N-788, TGACGTAC), which is almost identical to the
consensus CRE-motif of the somatostatin gene (that is,
TGACGTCA) [33]. Moreover, the stimulatory effect of NE
was inhibited in the presence of propranolol or yohimbine
(Fig. 9). These studies demonstrate that the NE-responsive
element is probably localized in the DNA fragment, ANG
N-806/-779 of the rat ANG gene.
On the other hand, we were surprised that the addition
Fig. 11. Inhibitory effect of Rp-cAMP or U73122 or staurosporine on the
expression of pOGH (ANG N-806/-779/-53/118) in OK 95 cells stimulated
by norepinephrine (1029 M). OK 95 cells were incubated for up to 24
hours in the presence of norepinephrine (1029 M) and 1027 M Rp-cAMP
or 1027 M U73122 or 1027 M staurosporine. Media were harvested and
assayed for the level of IR-hGH. The concentration of IR-hGH in the
absence of drugs is the control level (that is, 3.6 6 0.03 ng/ml of IR-hGH).
The inhibitory effect of Rp-cAMP or U73122 or staurosporine was
compared to cells, which were incubated with 1029 M norepinephrine.
Results are expressed as the mean 6 SD. of three determinations (*P #
0.05, **P # 0.01 and ***P # 0.005). Similar results were obtained from
two other experiments.
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of NE stimulated the expression of pOGH (ANG N-688/
118) in OK 688 cells. We did not find any consensus CRE
motif (that is, TGACGTCA) in the promoter region be-
tween N-688 to N1281. These observations suggest that
there might be an additional functional CRE-like in the
region between N-688 to N-281. Studies are underway in
our laboratory to identify the putative CRE-like in this
region.
The addition of 8-bromo-cAMP, forskolin or PMA alone
also stimulated the expression of the pOGH (ANG N-806/-
779/-53/118) in OK 95 cells compared to the control
(without the addition of 8-bromo-cAMP, forskolin or
PMA; Fig. 10). Furthermore, the stimulatory effect of NE
on the expression of the pOGH (ANG N-806/-779/-53/
118) in OK 95 cells was inhibited in the presence of
Rp-cAMP, staurosporine or U73122 (Fig. 11). These stud-
ies provide further support for the notion that the DNA
fragment, ANG N-806/-779 is the CRE of the rat ANG
gene.
Most convincingly, the addition of NE, forskolin or PMA
had no stimulatory effect on the expression of mutants of
the pOGH (ANG N-806/-779/-53/118) in OK 95/M1, OK
95/M2 and OK 95/M3 cells (Fig. 12), these studies demon-
strate that the DNA fragment, ANG N-806/-779 is the CRE
of the rat ANG gene.
At present, we do not know the exact molecular mecha-
nism(s) for the stimulatory effect of NE (that is, the
downstream pathway after the activation of PKA and PKC)
on the expression of pOGH (ANG N-1498/118) in OK 27
cells. One possible explanation may be that NE might
induce the phosphorylation of the nuclear cAMP-respon-
sive element binding protein (CREB) at serine 133 via
either PKA or PKC or a combination of both pathways,
since studies have shown that CREB can be phosphory-
lated at serine 133 by cAMP-dependent protein kinase A
[34], or by PKC [35, 36] and phosphorylation increases the
binding affinity of 43 kD-CREB to CRE [35, 36] and
subsequently enhances the gene expression. This possibility
is supported by our most recent studies which showed that
the addition of isoproterenol enhances the stimulating
effect of 43 kD-CREB on the expression of the pOGH
(ANG N-1498/118) in OK 27 cells [38]. Indeed, more
studies are ongoing to explore the molecular mechanism(s)
of the stimulatory effect of NE on the expression of the
ANG gene in OK cells.
Finally, it is evident that neither NE, forskolin, 8-Br-
cAMP nor PMA had any effect on the expression of pOGH
(ANG N-53/118) in OK 53 cells (Fig. 13). Since the
expression of the pOGH (ANG N-53/118) is driven by the
minimal promoter (that is, ANG N-53 to 118 contains the
putative “CCAT” and “TATA” boxes on nucleotides-50
and -30 upstream of the transcriptional site, respectively
[21]) of the rat ANG gene, these studies demonstrate that
the minimal promoter of the rat ANG gene was not
sufficient to respond to the addition of NE, forskolin,
8-Br-cAMP or PMA. The effect of NE, forskolin, 8-Br-
cAMP and PMA in OK 27 is mediated via the putative
CRE (ANG N-806 to N-779) in the 59-flanking region of
the rat ANG gene.
In summary, the present studies demonstrate that NE
stimulated the expression of pOGH (ANG N-1498/118) in
OK 27 cells. The stimulatory effect of NE was blocked by
the presence of propranolol or yohimbine or Rp-cAMP or
staurosporine or U73122. Furthermore, we demonstrate
Fig. 12. Effect of norepinephrine, 8-bromo-
cAMP and PMA on the expression of pOGH
(AnG N-806/-779/-53/118) and its mutants in
OK 95, OK 95/M1, OK 95/M2 and OK 95/M3
cells. Cells were incubated for up to 24 hours in
the presence of norepinephrine (1029 M) or
PMA (1027 M) or 8-bromo-cAMP (1023 M).
Media were harvested after 24 hours of
incubation and assayed for IR-hGH. The
concentration of IR-hGH in the absence of
norepinephrine or 8-bromo-cAMP or PMA
represents the control level (that is, OK 95,
3.8 6 0.2 ng/ml; OK 95/M1, 3.9 6 0.01 ng/ml;
OK 95/M2, 4.2 6 0.05 ng/ml; OK 95/M3, 3.1 6
0.14 ng/ml of IR-hGH). Each point represents
the mean 6 SD of three determinations (*P #
0.05, **P # 0.01 and ***P # 0.005). Symbols
are: (M) the control level; (o) incubation
medium in the presence of 1029 M NE; (f)
incubation medium in the presence of 1027 M
PMA; (;) medium in the presence of 1023 M
8-bromo-cAMP. Similar results were obtained
from four other experiments.
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that the effect of a combination of isoproterenol and
iodoclonidine on the expression of the pOGH (ANG
N-1498/118) in OK 27 cells was significantly higher when
compared to the addition of isoproterenol or iodoclonidine
alone. Finally, we demonstrate that the stimulatory effect
of NE is mediated via the putative cAMP-responsive
element (CRE) in the 59-flanking region of the rat ANG
gene. Our studies suggest that the activation of renal nerves
will release NE, which then stimulates the expression of the
ANG gene in the renal proximal tubule and increases the
formation of local renal Ang II. The elevated renal Ang II
subsequently modulates the sodium and fluid reabsorption
by the proximal tubular cells. Hence, the local intrarenal
RAS plays a significant role in the modulation of sodium
reabsorption.
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